FROG:NASDAQJFrog Ltd. Analysis
Data as of 2026-05-19 - not real-time
$67.91
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
JFrog (FROG) is trading at $67.91, roughly 17% above its DCF‑derived fair value of $56.92, indicating a premium valuation. The forward P/E of 60.5 far exceeds the industry average of 38.2, reinforcing the overvalued label. Nonetheless, the company posted a 25% year‑over‑year revenue increase to $531.8 M, with cloud revenues now representing just over 50% of the mix. Management forecast FY 2026 revenue of $628‑$632 M and announced a $300 M share buyback, fueling recent investor enthusiasm. Gross margins remain robust at 77%, but operating and net margins are still negative, and trailing EPS is –$0.53, highlighting the profitability gap. The “strong buy” analyst consensus (20 analysts) reflects optimism about the growth trajectory despite current losses.
On the technical side, the 20‑day SMA ($55.23) sits well below the current price, and both the MACD line (5.80) and its bullish signal reinforce upward momentum. However, the RSI of 71.8 places the stock in overbought territory, suggesting a near‑term correction risk. Volume is increasing, and the beta of ~1.27 signals higher sensitivity to market swings, consistent with the 30‑day volatility of 81%. The combination of strong top‑line growth, elevated valuation, and heightened volatility leads to a medium‑to‑high risk profile. Given the upside potential from continued cloud adoption and cash‑rich balance sheet, a cautious buy is warranted for the short and medium horizons. Over the longer term, investors should monitor margin improvement and cash‑flow conversion before confirming a sustained upside thesis.
On the technical side, the 20‑day SMA ($55.23) sits well below the current price, and both the MACD line (5.80) and its bullish signal reinforce upward momentum. However, the RSI of 71.8 places the stock in overbought territory, suggesting a near‑term correction risk. Volume is increasing, and the beta of ~1.27 signals higher sensitivity to market swings, consistent with the 30‑day volatility of 81%. The combination of strong top‑line growth, elevated valuation, and heightened volatility leads to a medium‑to‑high risk profile. Given the upside potential from continued cloud adoption and cash‑rich balance sheet, a cautious buy is warranted for the short and medium horizons. Over the longer term, investors should monitor margin improvement and cash‑flow conversion before confirming a sustained upside thesis.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 7/10
Key Factors
- Bullish MACD crossover
- Strong revenue growth and cloud mix
- Overbought RSI indicating near‑term pullback risk
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Projected FY2026 revenue $628‑$632 M
- $300 M share buyback supporting price
- Improving cash flow despite operating losses
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- High gross margin and cash reserves
- Long‑term demand for software supply‑chain solutions
- Potential margin expansion to achieve profitability
Key Metrics & Analysis
Financial Health
Revenue Growth25.20%
Profit Margin-13.50%
P/E Ratio60.5
ROE-8.65%
ROA-4.32%
Debt/Equity1.40
P/B Ratio9.2
Op. Cash Flow$145.7M
Free Cash Flow$174.9M
Industry P/E38.2
Technical Analysis
TrendNeutral
RSI71.8
Support$42.93
Resistance$72.06
MA 20$55.23
MA 50$48.78
MA 200$51.54
MACDBullish
VolumeIncreasing
Fear & Greed Index89.61
Valuation
Fair Value$56.92
Target Price$79.45
Upside/Downside16.99%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta1.27
Volatility81.27%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.